Day 2 of TG Rising Global Summit brought significant pharma-sector investments. Hetero Formulations committed ₹1,800 crore, Bharat Biotech CRDMO ₹1,000 crore, and Aurobindo Pharma ₹2,000 crore. Granules India pledged ₹1,200 crore, while a major biological vaccine project secured ₹4,000 crore. These investments mark a big boost to TGs life sciences ecosystem.